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Conclusions: Statistically signiﬁcant improvements to 3He-MRI to 
planning CT image registration can be achieved by using a dedicated 
imaging protocol that enables both 3He-MRI and planning CT to be 
acquired with similar breath holds and body position. Improved image 
registration accuracy will be beneﬁcial when performing functionally-
weighted IMRT planning.
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Background: We have previously reported that tumor opacity in 
the mediastinal window image in thin-section CT (TS-CT) is associ-
ated with prognosis of lung adenocarcinoma of 20 mm or smaller in 
diameter. However, pathological investigation of the tumor opacity in 
the mediastinal window has not been performed in detail. To investi-
gate the relationship between imaging and pathological ﬁndings, the 
solid lesion in the pathological preparation observed under a magnify-
ing glass (SLP) and tumor opacity in the mediastinal window image 
(TOM) in TS-CT were compared. The relationships of SLP and TOM 
with relapse were also investigated. 
Methods: The subjects were 115 patients with a lung adenocarcinoma 
of 20 mm or smaller in diameter who underwent surgical resection at 
the Kanagawa Cancer Center between January 1997 and October 2003. 
Pathological and imaging ﬁndings for these patients were re-investigat-
ed in this study. Patients with bronchioloalveolar carcinoma (BAC) that 
was undetectable in the mediastinal window image were excluded. SLP 
was deﬁned as follows: 1) regions with alveolar collapse, 2) regions 
accompanied by destruction of the alveolar framework, and 3) regions 
described in 2) accompanied by collagen ﬁbrotic foci. The maximum 
diameters of the tumor and SLP were measured in the pathological 
preparation, and the proportion of the maximum diameter of the SLP to 
the maximum tumor diameter was calculated as the pathological ratio. 
In TS-CT, the proportion of the reduction in the TOM maximum diam-
eter to the maximum diameter of the tumor opacity in the lung window 
was calculated as the reduction percentage. Correlations between the 
maximum SLP and TOM diameters and between the pathological ratio 
and the reduction percentage were investigated, and the association of 
relapse with SLP, TOM, the pathological ratio, and reduction percent-
age was also examined. 
Results: Strong Pearson correlations were noted between the maximum 
TOM and SLP diameters (correlation coefﬁcient: 0.852, p<0.0001) and 
between the reduction percentage and pathological ratio (correlation 
coefﬁcient: 0.895, p<0.0001). The maximum TOM and SLP diameters 
were not signiﬁcantly associated with relapse. However, the incidence 
of relapse was signiﬁcantly higher in patients with a reduction percent-
age of less than 50% by log-rank test; no relapse occurred in patients 
with a reduction percentage of 50% or higher. Similarly, the incidence 
of relapse was signiﬁcantly higher in patients with a pathological ratio 
of less than 50% by log-rank test; no relapse occurred in patients with a 
pathological ratio of 50% or higher in the pathological preparation. 
Conclusions: Use of the reduction percentage in TS-CT to classify 
lesions into two groups with different prognoses is valid based on the 
pathological investigation. Therefore, measurement of the reduction 
percentage and pathological ratio may allow prediction of cases of 
small adenocarcinoma of the lung with a good prognosis.
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Background: Response evaluation criteria in solid tumor (RECIST) is 
widely used as a standard method for evaluation of tumor response in 
clinical oncology. RECIST is based on uni-dimensional measurement 
of target lesions and is simpler than WHO criteria which are based on 
bi-dimensional measurement. In clinical practice, we sometimes use 
serum tumor markers to estimate tumor response as well, particularly 
when measurement of tumor size is difﬁcult. The aim of this study is to 
compare WHO criteria, RECIST, and serum carcinoembryonic antigen 
(CEA) level for evaluating tumor response to chemotherapy in non-
small cell lung cancer (NSCLC).
Patients and Methods: During an 11-year period from 1995 through 
2005, 24 NSCLC patients with high serum CEA level (> 5ng/ml) at 
presentation were retrospectively analyzed. They underwent pulmonary 
resection after induction chemotherapy. In each case, we compared 
histological response of tumor response of resected specimens.
Results: Using WHO criteria, nine and 15 patients achieved partial re-
sponse (PR) and no change (NC), respectively. With RECIST, PR was 
seen in 11 patients, stable disease (SD) in 13. Concordance between 
WHO and RECIST was 83 %. When we compare CEA level before 
chemotherapy with that obtained after chemotherapy, CEA levels 
signiﬁcantly decreased in PR group deﬁned by WHO criteria [26.3 
(median) ng/ml to 4.3 ng/ml, P = 0.008, wilcoxon t test] or RECIST 
[17.3 ng/ml to 4.4 ng/ml, P = 0.004, wilcoxon t test ]. On the contrary, 
in patients whose responses were NC or SD, there was no signiﬁcant 
difference [16.8 ng/ml to 9.9 ng/ml, P = 0.24, 16.8ng/ml to 19.6 ng/ml, 
P = 0.24, respectively]. In comparison of CEA level with histologic re-
sponse, CEA decreased signiﬁcantly in patients in whom less than one-
third of tumor cells were viable [17.3 ng/ml to 4.4 ng/ml, P = 0.008, 
wilcoxon t test] but not in whom more than two thirds of tumor cells 
were viable [16.8 ng/ml to 7.9 ng/ml, P = 0.06, wilcoxon t test]. From 
